Clinical trialNCT06097832RecruitingPhase 1/PHASE2Interventional

Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis

SponsorNexcella Inc.Enrollment40Light Chain (AL) Amyloidosis

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Sutter Health Alta Bates
Berkeley, California, United States
Oleg Krijanovski, MD
Recruiting
City of Hope
Duarte, California, United States
Michael A Rosenzweig, MD
Recruiting
University of California Los Angeles
Los Angeles, California, United States
Gary Schiller, MD
Recruiting
University of California Davis Medical Center
Sacramento, California, United States
Aaron Rosenberg, MD
Recruiting
Stanford University
Stanford, California, United States
Michaela Liedtke, MD
Recruiting
Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
Jonathan Kaufman, MD
Recruiting
the University of Kansas Cancer Center
Fairway, Kansas, United States
Al-Ola Abdallah, MD
Recruiting
Boston University Medical Center
Boston, Massachusetts, United States
Vaishali Sanchorawala, MD
Recruiting
Tufts Medical Center
Boston, Massachusetts, United States
Raymond Comenzo, MD
Recruiting
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
Jeffrey Zonder, MD
Recruiting
Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, United States
Binoy Yohannan, MD
Recruiting
Washington University Siteman Cancer Center
St Louis, Missouri, United States
Keith Stockerl-Goldstein, MD
Recruiting
Memorial Sloan Kettering Comprehensive Cancer Center
New York, New York, United States
Recruiting
University of Cincinnati Cancer Center
Cincinnati, Ohio, United States
Ed Faber, DO
Recruiting
Cleveland Clinic
Cleveland, Ohio, United States
Shahzad Raza, MD
Recruiting
Baptist Memorial Hospital
Memphis, Tennessee, United States
Brion Randolph, MD
Recruiting
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah, United States
Amandeep Godara, MD
Recruiting
Swedish Cancer Institute
Seattle, Washington, United States
Swathi Namburi, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 5 Jun 2024
Primary completion: 31 Dec 2026
Completion: 31 Jan 2039
Last update posted: 10 Jul 2025
Registered enrollment: 40
Registry id: NCT06097832

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.